Literature DB >> 3555293

Hypercalcemia of malignancy.

K L Insogna, A E Broadus.   

Abstract

Malignancy-associated hypercalcemia is a common and important clinical problem. Two major pathogenic mechanisms appear to be operative in this disorder: local osteolytic hypercalcemia and humoral hypercalcemia of malignancy. The clinical and biochemical features that distinguish these two processes are reviewed.

Entities:  

Mesh：

Year:  1987        PMID： 3555293     DOI： 10.1146/annurev.me.38.020187.001325

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  3 in total

1.  Native and a synthetic analogue of the malignancy-associated parathyroid hormone-like protein have in vitro transforming growth factor-like properties.

Authors:  K L Insogna; A F Stewart; C A Morris; L M Hough; L M Milstone; M Centrella
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 2.  Common emergencies in cancer medicine: metabolic syndromes.

Authors:  C R Thomas; N Dodhia
Journal:  J Natl Med Assoc       Date:  1991-09       Impact factor: 1.798

3.  Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years.

Authors:  Michael T Sheehan; Ya-Huei Li; Suhail A Doi; Adedayo A Onitilo
Journal:  J Endocr Soc       Date:  2021-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.